| Literature DB >> 35701630 |
Mei-Ling Xiang1, Bin-Yuan Hu1, Zi-Heng Qi1, Xiao-Na Wang1, Tian-Zhen Xie1, Zhao-Jie Wang1, Dan-Yu Ma1, Qi Zeng1, Xiao-Dong Luo2,3.
Abstract
Steroidal alkaloids possess the basic steroidal skeleton with a nitrogen atom in rings or side chains incorporated as an integral part of the molecule. They have demonstrated a wide range of biological activities, and some of them have even been developed as therapeutic drugs, such as abiraterone acetate (Zytiga®), a blockbuster drug, which has been used for the treatment of prostate cancer. Structurally diverse natural steroidal alkaloids present a wide spectrum of biological activities, which are attractive for natural product chemistry and medicinal chemistry communities. This review comprehensively covers the structural classification, isolation and various biological activities of 697 natural steroidal alkaloids discovered from 1926 to October 2021, with 363 references being cited.Entities:
Keywords: Apocynaceae; Bioactivities; Buxaceae; Chemistry; Liliaceae; Solanaceae; Steroidal alkaloids
Year: 2022 PMID: 35701630 PMCID: PMC9198197 DOI: 10.1007/s13659-022-00345-0
Source DB: PubMed Journal: Nat Prod Bioprospect ISSN: 2192-2209
Fig. 1Classification of steroidal alkaloids
Fig. 2Structures of conanine type steroidal alkaloids 1–36
Structures and sources of conanine type steroidal alkaloids 1–36
| No | Compounds | Substitution groups and others | Sources | References |
|---|---|---|---|---|
| Conessine | R1 = R2 = R5 = CH3; R3 = R4 = H | [ | ||
| 7 | R1 = R2 = R5 = CH3; R3 = R4 = H; 7- | [ | ||
| Regholarrhenine D | R1 = R2 = CH3; R3 = R4 = H; R5 = OH | [ | ||
| Antidysentericine | R1 = R2 = CH3; R3 = R5 = H; R4 = O | [ | ||
| Isoconessimine | R1 = R5 = CH3; R2 = R3 = R4 = H | [ | ||
| Holarrhetine | R1 = R2 = R5 = CH3; R3 = | [ | ||
| Holarrhesine | R1 = R4 = H; R2 = R5 = CH3; R3 = | [ | ||
| Conessimin | R1 = R2 = CH3; R3 = R4 = R5 = H | [ | ||
| Conarrhimin | R1 = R2 = R3 = R4 = R5 = H | [ | ||
| Conimin | R1 = CH3; R2 = R3 = R4 = R5 = H | [ | ||
| Mokluangin A | R1 = R3 = R5 = H; R2 = CH3; R4 = O | [ | ||
| Mokluangin C | R1 = R2 = R3 = R5 = H; R4 = O | [ | ||
| R1 = R2 = CH3; R3 = R4 = H; R5 = CHO | [ | |||
| Holonamine | R1 = | [ | ||
| 12 | R1 = H; R2 = | [ | ||
| 11 | R1 = R2 = | [ | ||
| Conkurchine | R1 = | [ | ||
| Malouetafrine | R1 = O; R2 = H; △4,5 | [ | ||
| Wrightiamine A | R1 = | [ | ||
| Regholarrhenine A | R1 = | [ | ||
| Regholarrhenine B | R1 = | [ | ||
| Holadiene | R1 = H; R2 = R3 = CH3 | [ | ||
| Kurchinidine | R1 = R2 = H; R3 = CH3 | [ | ||
| Kurchilidine (I) | R1 = R2 = H; R3 = | [ | ||
| Kuchamide (II) | R1 = OH; R2 = H; R3 = O | [ | ||
| Holamide | R1 = H; R2 = CONHCH3; R3 = CH3 | [ | ||
| Pubescinine | R1 = | [ | ||
| Regholarrhenine C | R1 = NHCH3; R2 = R3 = H | [ | ||
| Funtudienine | R1 = H; R2 = O; R3 = CH3 | [ | ||
| Kurcholessine | R = | [ | ||
| Regholarrhenine E | R = | [ | ||
| Mokluangin B | [ | |||
| Isoconkuressine | R1 = R2 = H | [ | ||
| Conkuressine | R1 = CH3; R2 = H | [ | ||
| Mokluangin D | [ | |||
| Irehline | [ |
Fig. 3Structures of paravallarine type steroidal alkaloids 37–44
Structures and sources of paravallarine type steroidal alkaloids 37–44
| No | Compounds | Substitution groups and others | Sources | References |
|---|---|---|---|---|
| 20- | [ | |||
| 3- | R1 = R2 = H | [ | ||
| Paravallarine | R1 = CH3; R2 = H | [ | ||
| 7 | R1 = CH3; R2 = OH | [ | ||
| Gitingensine | R = H | [ | ||
| R = CH3 | [ | |||
| R = Ac | [ | |||
| Kibalaurifoline | [ |
Fig. 4Structures of pregnane type steroidal alkaloids 45–177
Structures and sources of pregnane type steroidal alkaloids 45–177
| No | Compounds | Substitution groups and others | Sources | References |
|---|---|---|---|---|
| Saracocinaene | R1 = H; R2 = | [ | ||
| Sarconidine | R1 = H; R2 = | [ | ||
| Salonine B | R1 = H; R2 = | [ | ||
| Salignamine | R1 = R3 = H; R2 = | [ | ||
| 2-Hydroxysalignamine | R1 = | [ | ||
| R1 = H; R2 = | [ | |||
| Wallichimine A | R1 = H; R2 = | [ | ||
| Wallichimine B | R1 = R3 = H; R2 = | [ | ||
| Sarcodine | R1 = R2 = CH3; R3 = R4 = R5 = R6 = H; R7 = Ac | [ | ||
| Paxillarine A | R1 = Bz; R2 = R7 = CH3; R3 = | [ | ||
| Paxillarine B | R1 = Bz; R2 = R7 = CH3; R3 = | [ | ||
| Pachysamine B | R1 = Sen; R2 = R7 = CH3; R3 = R4 = R5 = R6 = H | [ | ||
| Pachysamine E | R1 = Sen; R2 = R3 = R4 = R5 = R6 = H; R7 = CH3 | [ | ||
| (+)-(20 | R1 = Bz; R2 = R3 = R5 = R6 = H; R4 = CH2; R7 = CH3 | [ | ||
| (+)-(20 | R1 = Bz; R2 = R3 = R4 = R6 = H; R5 = | [ | ||
| (+)-(20 | R1 = Sen; R2 = R3 = R4 = R6 = H; R5 = | [ | ||
| Hookerianine A | R1 = CO-Bn; R2 = R3 = R4 = R5 = R6 = H; R7 = CH3 | [ | ||
| Sarchookloide C | R1 = Tig; R2 = R3 = R4 = R5 = R6 = H; R7 = CH3 | [ | ||
| Pachyaximine A | R1 = R3 = R4 = H; R2 = OCH3; R5 = R6 = CH3 | [ | ||
| Sarsalignone | R1 = R4 = H; R2 = NH-Tig; R3 = O; R5 = R6 = CH3 | [ | ||
| Sarsaligenone | R1 = R4 = H; R2 = NH-Tig; R3 = O; R5 = R6 = CH3; △14,15 | [ | ||
| Epipachysamine- | R1 = R4 = H; R2 = NH-Sen; R3 = O; R5 = R6 = CH3 | [ | ||
| R1 = R4 = R5 = H; R2 = NH-Sen; R3 = O; R6 = CH3 | [ | |||
| Salignarine B | R1 = | [ | ||
| Salignarine C | R1 = | [ | ||
| Iso- | R1 = R3 = R4 = R5 = H; R2 = N(CH3)2; R6 = CHO | [ | ||
| Alkaloid C | R1 = R3 = R4 = H; R2 = OCH3; R5 = R6 = CH3 | [ | ||
| Salignarine F | R1 = R4 = H; R2 = NH-Tig; R3 = | [ | ||
| Saracosine | R1 = R3 = R4 = H; R2 = N(CH3)2; R5 = Ac; R6 = CHO | [ | ||
| Sarcodinine | R1 = R3 = R4 = H; R2 = N(CH3)2; R5 = R6 = CH3 | [ | ||
| 5,14-Dehydro- | R1 = R3 = R4 = H; R2 = NHCH3; R5 = Ac; R6 = CH3; △14,15 | [ | ||
| Holadysenterine | R1 = R3 = H; R2 = NH2; R4 = R5 = OH; R6 = Ac | [ | ||
| (20 | R1 = R3 = R4 = R5 = H; R2 = N(CH3)2; R6 = COCH = CHph | [ | ||
| SarcovagineA | R1 = R4 = | [ | ||
| Sarcovagine B | R1 = | [ | ||
| Sarcovagine C | R1 = R3 = H; R2 = Tig; R4 = | [ | ||
| R1 = R2 = R4 = H; R3 = CHO; R5 = R6 = CH3 | [ | |||
| Vaganine A | R1 = R2 = H; R3 = Sen; R4 = | [ | ||
| Sarcorine | R1 = R2 = R4 = H; R3 = Ac; R5 = R6 = CH3 | [ | ||
| R1 = R2 = R4 = H; R3 = R6 = CH3; R5 = Ac | [ | |||
| Saligcinnamide | R1 = R4 = H; R2 = R5 = R6 = CH3; R3 = Cin | [ | ||
| R1 = R4 = H; R2 = R5 = R6 = CH3; R3 = Bz | [ | |||
| Epipachysamine D | R1 = R2 = R4 = H; R3 = Bz; R5 = R6 = CH3 | [ | ||
| Salignenamide A | R1 = R2 = R4 = H; R3 = COCHC(CH3)CH(CH3)CH3; R5 = R6 = CH3 | [ | ||
| 2,4-Diacetoxyepipachysamine D | R1 = | [ | ||
| Iso- | R1 = R4 = R5 = H; R2 = R3 = CH3; R6 = CHO | [ | ||
| Epipachysamine E | R1 = R3 = R4 = H; R2 = Sen; R5 = R6 = CH3 | [ | ||
| 11-Hydroxyepipachysamine E | R1 = R2 = R4 = H; R3 = Sen; R5 = R6 = CH3; 11-OH | [ | ||
| Saligenamide C | R1 = | [ | ||
| Saligenamide F | R1 = R4 = H; R2 = CH3; R3 = COCHC(CH3)CH(CH3)CH3; R5 = R6 = CH3 | [ | ||
| 2 | R1 = | [ | ||
| Axillarine C | R1 = | [ | ||
| Axillarine F | R1 = | [ | ||
| Salonine A | R1 = | [ | ||
| Dictyophlebine | R1 = R2 = R4 = H; R3 = R5 = R6 = CH3 | [ | ||
| Hookerianamine A | R1 = R2 = R4 = H; R3 = R5 = R6 = CH3; △14,15 | [ | ||
| Isosarcodine | R1 = R4 = H; R2 = R5 = R6 = CH3; R3 = Ac | [ | ||
| Hookerianamide B | R1 = | [ | ||
| Hookerianamide C | R1 = | [ | ||
| Hookerianamide D | R1 = R4 = H; R2 = R5 = CH3; R3 = COCHC(CH3)CH(CH3)CH3; R6 = CHO | [ | ||
| Hookerianamide E | R1 = | [ | ||
| Hookerianamide G | R1 = H; R2 = R5 = R6 = CH3; R3 = Bz; R4 = | [ | ||
| Hookerianamide I | R1 = R4 = R5 = H; R2 = R6 = CH3; R3 = Bz | [ | ||
| Chonemorphine | R1 = R2 = R3 = R4 = H; R5 = R6 = CH3 | [ | ||
| R1 = R4 = H; R2 = R3 = R5 = R6 = CH3 | [ | |||
| Pachysamine J | R1 = | [ | ||
| Pachysamine O | R1 = R2 = R4 = H; R3 = Cin; R5 = R6 = CH3 | [ | ||
| Pachysamine P | R1 = R2 = H; R3 = COCH2C(CH3)C(CH3)CH3; R4 = | [ | ||
| (20 | R1 = | [ | ||
| (20 | R1 = R4 = R5 = H; R2 = R3 = CH3; R6 = COCH = CHph | [ | ||
| (20 | R1 = R4 = H; R2 = R3 = R6 = CH3; R5 = Bz | [ | ||
| Sarcovagine D | R1 = Tig; R2 = O; R3 = R4 = H; R5 = CH3 | [ | ||
| Sarcovagenine C | R1 = Tig; R2 = O;R3 = R4 = H; R5 = CH3; △16,17 | [ | ||
| Axillaridine A | R1 = Bz; R2 = O; R3 = R4 = H; R5 = CH3 | [ | ||
| 2,3-Dehydrosarsalignone | R1 = Tig; R2 = O; R3 = R4 = H; R5 = CH3; △5,6 | [ | ||
| 14,15-Dehydrosarcovagine D | R1 = Tig; R2 = O; R3 = R4 = H; R5 = CH3; △14,15 | [ | ||
| Phulchowkiamide A | R1 = Tig; R2 = O; R3 = R4 = R5 = H | [ | ||
| Hookerianamide F | R1 = Tig; R2 = O; R3 = R4 = R5 = H; △14,15 | [ | ||
| Hookerianamide H | R1 = CHO; R2 = O; R3 = R4 = H; R5 = CH3 | [ | ||
| (+)-(20 | R1 = Bz; R2 = | [ | ||
| Pachysamine L | R1 = Tig; R2 = | [ | ||
| Pachysamine M | R1 = Sen; R2 = O; R3 = R4 = H; R5 = CH3 | [ | ||
| Pachysamine N | R1 = Sen; R2 = O; R3 = H; R4 = | [ | ||
| Sarsaligenine A | R1 = Sen; R2 = O; R3 = R4 = H; R5 = CH3; △16,17 | [ | ||
| Sarsaligenine B | R1 = Sen; R2 = O; R3 = | [ | ||
| Sarcovagenines A | R1 = R3 = | [ | ||
| Sarcovagenines B | R1 = | [ | ||
| Salignarine D | R1 = R3 = H; R2 = Sen; R4 = CH3 | [ | ||
| (−)-Vaganine D | R1 = H; R2 = Sen; R3 = | [ | ||
| (+)-Nepapakistamine A | R1 = R3 = | [ | ||
| 5,6-Dihydrosarconidine | R1 = R3 = H; R2 = R4 = CH3 | [ | ||
| 16-Dehydrosarcorine | R1 = R3 = H; R3 = Ac; R4 = CH3 | [ | ||
| Hookerianamide A | R1 = R3 = | [ | ||
| Saligenamide B | R1 = | [ | ||
| Salignarine E | R1 = H; R2 = Tig | [ | ||
| Saligenamide D | R1 = | [ | ||
| 2-Hydroxysalignarine E | R1 = | [ | ||
| Salonine C | R1 = H; R2 = Tig; △14,15 | [ | ||
| [ | ||||
| [ | ||||
| Holamine | R1 = | [ | ||
| 3 | R1 = | [ | ||
| 15 | R1 = | [ | ||
| Pachysanone | R1 = O; R2 = H; R3 = | [ | ||
| Pachysanonin | R1 = | [ | ||
| Pachysamine Q | R1 = | [ | ||
| Pachysamine R | R1 = | [ | ||
| Terminamine F | R1 = | [ | ||
| Terminamine G | R1 = | [ | ||
| Funtumine | R1 = | [ | ||
| (+)-(20 | R1 = R3 = R4 = H; R2 = O; △1,2 | [ | ||
| (+)-(20 | R1 = R3 = H; R2 = O; R4 = | [ | ||
| Pachystermine A | R1 = R3 = R4 = H; R2 = O | [ | ||
| (+)-(20 | R1 = R3 = H; R2 = O; R4 = | [ | ||
| Terminamine A | R1 = R3 = H; R2 = O; R4 = | [ | ||
| Terminamine B | R1 = | [ | ||
| Terminamine C | R1 = | [ | ||
| Pachystermine B | R1 = R3 = R4 = H; R2 = | [ | ||
| Terminamine D | R = OH | [ | ||
| Terminamine E | R = H | [ | ||
| (+)-(20 | [ | |||
| Spiropachysine | [ | |||
| Salignarine A | [ | |||
| Epoxynepapakistamin A | R1 = R3 = | [ | ||
| Epoxysarcovagenine D | R1 = R4 = H; R2 = | [ | ||
| ( | R1 = R3 = R4 = H; R2 = | [ | ||
| Hookerianine B | R1 = R3 = H; R2 = | [ | ||
| [ | ||||
| Pachysamines K | R1 = R4 = H; R2 = | [ | ||
| Archosokloide A | R1 = R5 = H; R2 = | [ | ||
| Sarchookloide B | R1 = R4 = R5 = H; R2 = | [ | ||
| 4-Dehydroxyepisarcovagine A | R1 = | [ | ||
| (20 | [ |
Structures and sources of 9β,19-Cyclo-14α-methylpregnane type steroidal alkaloids 178–227
| No | Compounds | Substitution groups and others | Sources | References |
|---|---|---|---|---|
| Cyclobuxine | R1 = H; R2 = | [ | ||
| Cyclobuxamidine | R1 = Ac; R2 = H | [ | ||
| Cyclobuxoviridine | R1 = O; R2 = R4 = CH3; R3 = H; △1,2 | [ | ||
| Buxbodine A | R1 = R3 = H; R2 = R4 = CH3 | [ | ||
| Buxbodine B | R1 = O; R2 = R4 = CH3; R3 = | [ | ||
| R1 = O; R2 = CH3; R3 = R4 = H | [ | |||
| Cyclimikuranine | R1 = O; R2 = R4 = CH3; R3 = H | [ | ||
| R1 = O; R2 = R4 = CH3; R3 = | [ | |||
| Buxmicrophylline K | R1 = | [ | ||
| R1 = O; R2 = CH3; R3 = | [ | |||
| 31-Demethylcyclobuxoviridine | R1 = O; R2 = H; R3 = H; R4 = CH3; △1,2 | [ | ||
| Cyclomicrobuxamine | R1 = R3 = H; R2 = CH2 | [ | ||
| Cyclomicrobuxeine | R1 = R3 = H; R2 = CH2; △16,17 | [ | ||
| 30-Hydroxycyclomicobuxene | R1 = R3 = H; R2 = CH2OH; △4,5 | [ | ||
| Buxippine K | R1 = CH3; R2 = CH2; R3 = | [ | ||
| Cyclorolfeine | [ | |||
| Cyclobuxomicreinine | [ | |||
| Isodihydrocyclomicrophylline A | R1 = R2 = R5 = R6 = CH3; R3 = CH2OH; R4 = | [ | ||
| Buxasamarine | R1 = R2 = R3 = CH3; R4 = | [ | ||
| Buxmicrophylline C | R1 = H; R2 = Isobu; R3 = CH2OH; R4 = | [ | ||
| Buxbodine D | R1 = R2 = R3 = CH3; R4 = R5 = H; R6 = Ac; △6,7 | [ | ||
| Buxbodine E | R1 = R2 = R3 = CH3; R4 = R5 = R6 = H; △6,7 | [ | ||
| Buxakashmiramine | R1 = Syr; R2 = R5 = R6 = CH3; R3 = CH2OH; R4 = H | [ | ||
| Cycloprotobuxine C | R1 = R2 = R3 = R5 = R6 = CH3; R4 = H; △6,7 | [ | ||
| Cyclovirobuxeine A | R1 = R2 = R3 = R5 = R6 = CH3; R4 = | [ | ||
| Cyclovirobuxine D | R1 = R5 = H; R2 = R3 = R6 = CH3; R4 = | [ | ||
| Hyrcamine | R1 = H R2 = Tig; R3 = CH2OH; R4 = | [ | ||
| Buxidine | R1 = H R2 = Bz; R3 = CH2OH; R4 = | [ | ||
| Buxandrine | R1 = H R2 = Bz; R3 = CH2OH; R4 = | [ | ||
| Buxrugulosamine | R1 = H; R2 = Ac; R3 = CH3; R4 = H; R5 = H; R6 = CH3 | [ | ||
| Buxmicrophylline E | R1 = H; R2 = Bz; R3 = CH2OH; R4 = O-Bz; R5 = R6 = CH3 | [ | ||
| Buxmicrophylline F | R1 = H; R2 = Isobu; R3 = CH2OH; R4 = O-Bz; R5 = R6 = CH3; △6,7 | [ | ||
| Buxmicrophylline G | R1 = H; R2 = Isofer; R3 = CH2OH; R4 = | [ | ||
| Buxmicrophylline H | R1 = H; R2 = Syr; R3 = CH2OH; R4 = | [ | ||
| Cyclonataminol | R1 = R2 = R3 = R5 = R6 = CH3; R4 = | [ | ||
| [ | ||||
| Buxozine C | [ | |||
| Sempervirone | [ | |||
| Buxmicrophylline D | R1 = R2 = CH3; R3 = R4 = H | [ | ||
| Buxmicrophylline I | R1 = R2 = R3 = H; R4 = Syr | [ | ||
| Buxmicrophylline J | R1 = H; R2 = R3 = CH3; R4 = Bz | [ | ||
| Buxmicrophylline P | R1 = R2 = H; R3 = | [ | ||
| Buxmicrophylline Q | R1 = R2 = H; R3 = | [ | ||
| Buxmicrophylline R | R1 = R2 = H; R3 = | [ | ||
| Buxmicrophylline B | R1 = R3 = H; R2 = CH3 | [ | ||
| R1 = R3 = H; R2 = CH3; △7,8 | [ | |||
| R1 = R2 = H; R3 = CH3; △7,8 | [ | |||
| Buxbodine C | R1 = R2 = CH3; R3 = H; △6,7 | [ | ||
| Cyclobuxaphylline | R1 = R2 = CH3; R3 = H | [ | ||
| 17-Oxocycloprotobuxine | [ |
Fig. 5Structures of 9β,19-cyclo-14α-methylpregnane type steroidal alkaloids 178–227
Fig. 6Structures of 9(10 → 19)abeo-14α-methylpregnane type steroidal alkaloids 228–293
Structures and sources of 9(10 → 19)abeo-14α-methylpregnane type steroidal alkaloids 228–293
| No | Compounds | Substitution groups and others | Sources | References |
|---|---|---|---|---|
| Buxamine A | R1 = N(CH3)2; R2 = R4 = R5 = CH3; R3 = H | [ | ||
| Buxamine C | R1 = NHCH3; R2 = R4 = R5 = CH3; R3 = H | [ | ||
| 30- | R1 = H; R2 = CH2O-Bz; R3 = H; R4 = R5 = CH3 | [ | ||
| 30-Hydroxybuxamine A | R1 = R4 = R5 = CH3; R2 = CH2OH; R3 = H | [ | ||
| 30-Norbuxamine A | R1 = R4 = R5 = CH3; R2 = R3 = H | [ | ||
| R1 = NH-Bz; R2 = COH; R3 = | [ | |||
| 16 | R1 = NH-Bz; R2 = R4 = R5 = CH3; R3 = | [ | ||
| Buxaminol C | R1 = NHCH3; R2 = R4 = R5 = CH3; R3 = | [ | ||
| Papilamine | R1 = NHCH3; R2 = R5 = CH3; R3 = R4 = H | [ | ||
| 16 | R1 = NH-Ac; R2 = R4 = R5 = CH3; R3 = | [ | ||
| (+)-Benzoylbuxidienine | R1 = NH-Bz; R2 = R4 = R5 = CH3; R3 = | [ | ||
| Buxamine F | R1 = NH2; R2 = R4 = R5 = CH3; R3 = H | [ | ||
| R1 = N(CH3)2; R2 = CH3; R3 = | [ | |||
| R1 = N(CH3)2; R2 = CH3; R3 = | [ | |||
| R1 = NHCH3; R2 = CH3; R3 = H; R4 = H; R5 = Ac | [ | |||
| R1 = N(CH3)2; R2 = CH3; R3 = H; R4 = H; R5 = Ac | [ | |||
| Buxakarachiamine | R1 = NH-COCH(OH)CH(CH3)2; R2 = CH2OH; R3 = H; R4 = R5 = CH3 | [ | ||
| Buxahejramine | R1 = NH-COCH(OH)CH(CH3)CH2CH; R2 = CH2OH; R3 = H; R4 = R5 = CH3 | [ | ||
| 31-Demethylbuxaminol A | R1 = N(CH3)2; R2 = H; R3 = | [ | ||
| Buxaminol A | R1 = N(CH3)2; R2 = R4 = R5 = CH3; R3 = | [ | ||
| Moenjodarmine | R1 = CH3; R2 = R3 = H; R4 = N(CH3)2 | [ | ||
| R1 = CH3; R2 = R3 = H; R4 = NH2 | [ | |||
| Homomoenjodaramine | R1 = R2 = CH3; R3 = H; R4 = N(CH3)2 | [ | ||
| Buxhyrcamine | R1 = R2 = R3 = H; R4 = N(CH3) 2 | [ | ||
| Macowanioxazine | R1 = CH3; R2 = H; R3 = | [ | ||
| 16 | R1 = CH3; R2 = H; R3 = | [ | ||
| Macowanitriene | R1 = CH3; R2 = R3 = H; R4 = N(CH3) 2; △1,2 | [ | ||
| Papillotrienine | R1 = | [ | ||
| R1 = | [ | |||
| Hyrcatrienine | R1 = | [ | ||
| 31-Hydroxybuxatrienone | R1 = O; R2 = CH2OH; R3 = CH3 | [ | ||
| R1 = H; R2 = H | [ | |||
| 6-Hydroxy- | R1 = OH; R2 = H | [ | ||
| R1 = Bz; R2 = OH; R3 = R4 = H | [ | |||
| R1 = Bz; R2 = OH; R3 = | [ | |||
| Buxusemine B | R1 = Bz; R2 = OH; R3 = | [ | ||
| Buxusemine C | R1 = Bz; R2 = R3 = R4 = H | [ | ||
| (−)-16-Hydroxybuxaminone | R1 = CH3; R2 = | [ | ||
| Semperviraminone | R1 = CH3; R2 = H; △1,10; △16,17 | [ | ||
| R1 = R2 = H; △1,10; △16,17 | [ | |||
| Buxalongifolamidine | R1 = R4 = H; R2 = NH-Bz; R3 = CH2OH; R5 = | [ | ||
| Semperviraminol | R1 = | [ | ||
| R1 = R4 = R6 = H; R2 = NH-Bz; R5 = | [ | |||
| R1 = R4 = R6 = H; R2 = NH-Tig; R3 = CH3; R5 = | [ | |||
| R1 = R4 = R6 = H; R2 = Isobu; R3 = CH3; R5 = | [ | |||
| Hyrcanone | R1 = R4 = R6 = H; R2 = NH-Bz; R3 = CH3; R5 = /; 11-O; △1,10 | [ | ||
| 2 | R1 = R6 = | [ | ||
| Macowamine | R1 = R4 = R5 = R6 = H; R2 = NCH3-Van; R3 = CH2OH; △9,11 | [ | ||
| 16 | R1 = R4 = H; R2 = NH-Bz; R3 = CH3; R5 = | [ | ||
| R1 = R4 = R5 = H; R2 = N(CH3)2; R3 = R6 = CH3 | [ | |||
| (+)-16 | R1 = R4 = H; R2 = NH-Bz; R3 = CH2OAc; R5 = | [ | ||
| Hyrcanol | R1 = | [ | ||
| Buxabenzacinine | R1 = R3 = H; R2 = NH-Bz; R4 = CH2OAc; R5 = | [ | ||
| 2 | R1 = | [ | ||
| Cyclovirobuxeine F | R1 = R2 = H | [ | ||
| (+)- | R1 = | [ | ||
| (+)-7-deoxy- | R1 = | [ | ||
| 2 | R1 = OAc; R2 = Bz; R3 = H; R4 = | [ | ||
| Buxapapillinine | R1 = OAc; R2 = Bz; R3 = | [ | ||
| Buxusemine D | R1 = R4 = H; R2 = Bz; R3 = | [ | ||
| Papillozine C | [ | |||
| Sempervirooxazolidine | [ | |||
| Hyrcanine | [ | |||
| Buxaquamarine | [ | |||
| [ | ||||
| 17-Oxo-3-benzoylbuxadine | [ |
Fig. 7Structures of cevanine type steroidal alkaloids 294–384
Structures and sources of cevanine type steroidal alkaloids 294–384
| No | Compounds | Substitution groups and others | Sources | References |
|---|---|---|---|---|
| Veratrenone | [ | |||
| Shinonomenine | R1 = | [ | ||
| Veraflorizine | R1 = | [ | ||
| Fritillarizine | R1 = | [ | ||
| Veramarine-3-yl formate | R1 = | [ | ||
| Baimonidine: | R1 = | [ | ||
| Isoverticine | R1 = R2 = | [ | ||
| Isobaimonidine | R1 = R2 = | [ | ||
| 3- | R1 = | [ | ||
| Ebeiedinone | R1 = | [ | ||
| Delafrine | R1 = R2 = | [ | ||
| Delafrinone | R1 = | [ | ||
| Zhebeinine | R1 = | [ | ||
| Puqiedinone | R1 = | [ | ||
| Zhebeinone | R1 = | [ | ||
| Dongbeinine | R1 = | [ | ||
| Dongbeirine | R1 = | [ | ||
| Ebeiedine | R1 = R2 = | [ | ||
| Impericine | R1 = R2 = | [ | ||
| Forticine | R1 = R2 = | [ | ||
| Lichuanine | R1 = R2 = | [ | ||
| Puqiedine | R1 = R2 = | [ | ||
| 3 | R1 = R3 = | [ | ||
| Yibeinone F | R1 = O- | [ | ||
| Verticine | R1 = | [ | ||
| Verticinone | R1 = O; R2 = OH; R3 = CH3 | [ | ||
| Isoverticine- | R1 = | [ | ||
| Lichuanisinine | R1 = | [ | ||
| Pingbeimine A | R1 = | [ | ||
| Pingbeimine B | R1 = | [ | ||
| Pingbeimine C | R1 = O; R2 = H | [ | ||
| Delavine | R1 = R2 = | [ | ||
| Hupeheninoside | R1 = | [ | ||
| Delavinone | R1 = R3 = H; R2 = O; R4 = CH3 | [ | ||
| Hupehenirine | R1 = O; R2 = | [ | ||
| Yibeinoside A | R1 = | [ | ||
| Hupehemonoside | R1 = | [ | ||
| Delavine-3- | R1 = | [ | ||
| Yubeinine | R1 = | [ | ||
| Yubeiside | R1 = O; R2 = | [ | ||
| Hupeheninate | R1 = Ac; R2 = | [ | ||
| Imperialine | R1 = | [ | ||
| Chuanbeinone | R1 = R3 = H; R2 = O; R4 = CH3; R5 = | [ | ||
| Hareperminside | R1 = | [ | ||
| Tortifoline | R1 = R4 = H; R2 = | [ | ||
| Siechuansine | R1 = H; R2 = | [ | ||
| Songbeinone | R1 = R4 = H; R2 = O; R3 = CH3; R5 = | [ | ||
| Yibeinoside B | R1 = | [ | ||
| Persicanidine B/Harepermine | R1 = R3 = H; R2 = | [ | ||
| Yibeinone D | R1 = | [ | ||
| Wanpeinine A | R1 = | [ | ||
| Persicanidine A | R1 = | [ | ||
| Yibeirine | R1 = | [ | ||
| Yibeinone C | R1 = O; R2 = OH; R3 = CH3; R4 = | [ | ||
| Yibeinone E | R1 = O; R2 = CH3; R3 = H; R4 = | [ | ||
| Germaline | R1 = R3 = R6 = H; R2 = COC(OH)(CH3)CH(OAc)CH3; R4 = | [ | ||
| Germatetrine | R1 = R3 = R6 = H; R2 = COC(OH)(CH3)CH(OAc)CH3; R4 = | [ | ||
| Stenophylline A | R1 = R3 = R6 = H; R2 = Ang; R4 = | [ | ||
| Maackinine | R1 = R3 = R6 = H; R2 = Ang; R4 = | [ | ||
| Verussurinine | R1 = R2 = R3 = H; R4 = R5 = | [ | ||
| Verussurine | R1 = R3 = R6 = H; R2 = Ver; R4 = | [ | ||
| Verabenzoamine | R1 = R3 = R6 = H; R2 = Ver; R4 = | [ | ||
| Angeloylzygadenine | R1 = R3 = R4 = R6 = H; R2 = Ang; R5 = | [ | ||
| Zygadenine | R1 = R2 = R3 = R4 = R6 = H; R5 = | [ | ||
| Germine | R1 = R2 = R3 = R6 = H; R4 = | [ | ||
| 15- | R1 = R2 = R3 = R6 = H; R4 = | [ | ||
| Neojerminalanine | R1 = | [ | ||
| 15-Angeloylgermine | R1 = R2 = R3 = R6 = H; R4 = | [ | ||
| R1 = R3 = R6 = H; R2 = Ac; R4 = | [ | |||
| R1 = R3 = R5 = R6 = H; R2 = Ver; R4 = | [ | |||
| R1 = R3 = R6 = H; R2 = Ac; R4 = | [ | |||
| R1 = R3 = R6 = H; R2 = Ver; R4 = | [ | |||
| 15- | R1 = R6 = H; R2 = Ver; R3 = R4 = | [ | ||
| Veramadine A | R1 = R3 = R5 = R6 = H; R2 = Ver; R4 = | [ | ||
| Veramadine B | R1 = R2 = R3 = R4 = R5 = R6 = H | [ | ||
| Ebeienine | R1 = R2 = | [ | ||
| Ziebeimine | R1 = | [ | ||
| Heilonine | [ | |||
| Pingbeinone | [ | |||
| Ussuriedine | R1 = | [ | ||
| Ussuriedinone | R1 = O; R2 = H | [ | ||
| Ussurienine | R1 = | [ | ||
| Ussurienone | R1 = O; R2 = CH3 | [ | ||
| Taipaienine | R1 = H; R2 = | [ | ||
| Yibeisine | R1 = OH; R2 = | [ | ||
| Neoverataline A | R = H | [ | ||
| Neoverataline B | R = | [ | ||
| R = Ver | [ | |||
| Frithunbol A | [ | |||
| Frititorine A | [ | |||
| Frititorine B | R = | [ |
Fig. 8Structures of veratramine type steroidal alkaloids 385–411
Structures and sources of veratramine type steroidal alkaloids 385–411
| No | Compounds | Substitution groups and others | Sources | References |
|---|---|---|---|---|
| Hosukinidine | R1 = R2 = R4 = H; R3 = | [ | ||
| Veratramanol A | R1 = X; R2 = | [ | ||
| Veratramine- | [ | |||
| Ningpeisine | R = H | [ | ||
| Ningpeisinoside | R = | [ | ||
| 20-Isoveratramine | R1 = H; R2 = H; R3 = | [ | ||
| Veratramine-3-yl acetate | R1 = Ac; R2 = H; R3 = | [ | ||
| Veratramine | R1 = H; R2 = H; R3 = | [ | ||
| Veratrosine | R1 = | [ | ||
| Veratravine E | R1 = H; R2 = OH; R3 = | [ | ||
| 23- | R = | [ | ||
| (22 | R = | [ | ||
| Veramarine | [ | |||
| Impranine | R = O | [ | ||
| Dihydroimpranine | R = | [ | ||
| Puqienine A | R = | [ | ||
| Puqienine B | R = O | [ | ||
| Yibeinone B | R1 = H; R2 = | [ | ||
| Veratravine F | R1 = | [ | ||
| Veratravine G | R1 = | [ | ||
| Veratravine A | R = | [ | ||
| Veratravine B | [ | |||
| Veratravine C | [ | |||
| Veratravine D | [ | |||
| △5(20 | R = | [ | ||
| △5(20 | R = | [ | ||
| Zhebeisine | [ |
Fig. 9Structures of jervine type steroidal alkaloids 412–440
Structures and sources of jervine type steroidal alkaloids 412–440
| No | Compounds | Substitution groups and others | Sources | References |
|---|---|---|---|---|
| Verdine | R1 = | [ | ||
| 1-Hydroxy-5,6-dihydrojervine | R1 = | [ | ||
| 2 | R1 = R2 = | [ | ||
| (1 | R1 = | [ | ||
| Veratraline C | R1 = R3 = | [ | ||
| Kuroyurinidine | R1 = | [ | ||
| 23-Isokuroyurinidine | R1 = | [ | ||
| Frithunbol B | R1 = H; R2 = | [ | ||
| Frititorinec | R1 = H; R2 = | [ | ||
| Yibeissine | R1 = | [ | ||
| Tortifolisine | R1 = H; R2 = | [ | ||
| Verapatulin | R1 = H; R2 = O; R3 = COOCH3 | [ | ||
| R1 = Ac; R2 = O; R3 = H | [ | |||
| Methyljervine- | R1 = H; R2 = O; R3 = (CH2)2COOCH3 | [ | ||
| Neoverapatuline | R1 = H; R2 = | [ | ||
| Jervine | R1 = R3 = H; R2 = O | [ | ||
| Jervine-3-yl formate | R1 = COH; R2 = O; R3 = H | [ | ||
| Veratraline A | R1 = H; R2 = O; R3 = CH2NHAc | [ | ||
| Jervinone | [ | |||
| 23-Methoxycyclopamine | R1 = H; R2 = CH3 | [ | ||
| Cyclopamine | R1 = R2 = H | [ | ||
| 23-methoxycyclopamine 3- | R1 = | [ | ||
| Veraussine A | R1 = R3 = | [ | ||
| Veraussine B | R1 = R3 = | [ | ||
| (1 | R1 = R3 = | [ | ||
| 6,7-Epoxyverdine | [ | |||
| Jerv-5,11-diene-3 | [ | |||
| Yibeinone A | [ | |||
| Veratraline B | [ |
Fig. 10Structures of spirosolane type steroidal alkaloids 441–526
Structures and sources of spirosolane type steroidal alkaloids 441–526
| No | Compounds | Substitution groups and others | Sources | References |
|---|---|---|---|---|
| R1 = Solatriose; R2 = R3 = R5 = H; R4 = CH3 | [ | |||
| Soladulcidine | R1 = R2 = R3 = R4 = R5 = H | [ | ||
| Soladulcine A | R1 = Chacotriose; R2 = R3 = R5 = H; R4 = CH3 | [ | ||
| Soladulcine B | R1 = Lycotetraose; R2 = R3 = R5 = H; R4 = CH3 | [ | ||
| Dihydrosolasuaveoline | R1 = | [ | ||
| Solalyratine A | R1 = | [ | ||
| Solalyratine B | R1 = [ | [ | ||
| Esculeoside A | R1 = Lycotetraose; R2 = OAc; R3 = R4 = H; R5 = CH2- | [ | ||
| Lycotetraose G | R1 = Lycotetraose; R2 = OAc; R3 = | [ | ||
| 22-Imido-3-[4ʹ-(6ʺ-deoxy- | R1 = | [ | ||
| Neorickiioside B | R1 = Lycotetraose; R2 = OH; R3 = R5 = H; R4 = CH3 | [ | ||
| R = | [ | |||
| Dihydro- | R = Chacotriose | [ | ||
| Polyanine | R = | [ | ||
| Sisunine | R = Commertetraose | [ | ||
| Tomatidine-3- | R = | [ | ||
| Tomatidine-3- | R = | [ | ||
| Tomatidine | R = H | [ | ||
| R = Lycotetraose | L | [ | ||
| R = | [ | |||
| R = | [ | |||
| R = | [ | |||
| R = | [ | |||
| R = | [ | |||
| R = | [ | |||
| 22,25-Diepisycophantine | R = [D-Xyl-(1 → 2)- | [ | ||
| Solaculine A | R = [D-Xyl-(1 → 2)- | [ | ||
| Tomatidenol | R = H | [ | ||
| (22 | R = | [ | ||
| R = | [ | |||
| R = Solatriose | [ | |||
| Dehydrotomatine | R = Lycotetraose | [ | ||
| R = Chacotriose | [ | |||
| 3- | R1 = Lycotetraose; R2 = R3 = R4 = R5 = H | [ | ||
| Spirosolane | R1 = Chacotriose; R2 = R4 = H; R3 = | [ | ||
| Solaverine I | R1 = Chacotriose; R2 = R3 = R5 = H; R4 = OH | [ | ||
| Solaverine II | R1 = | [ | ||
| Solaverine III | R1 = Chacotriose;R2 = R3 = H; R4 = R5 = OH | [ | ||
| Incanumine | R1 = [D-Xyl-(1 → 4)- | [ | ||
| (23 | R1 = | [ | ||
| R1 = | [ | |||
| Anguivine | R1 = [D-Xyl-(1 → 3)- | [ | ||
| Robustine | R1 = | [ | ||
| Ravifoline | R1 = | [ | ||
| (3 | R1 = | [ | ||
| Robeneoside A | R1 = Chacotriose; R2 = R4 = R5 = H; R3 = | [ | ||
| 3- | R1 = | [ | ||
| Sycophantine | R1 = [D-Xyl-(1 → 2)- | [ | ||
| Solanelagnin | R1 = | [ | ||
| 12-Hydroxysolasonine | R1 = Solatriose; R2 = R4 = R5 = H; R3 = | [ | ||
| Isoanguivine | R1 = | [ | ||
| Solashabanine | R1 = [D-Glc-(1 → 6)- | [ | ||
| (23 | R1 = | [ | ||
| Solasuaveoline | R1 = | [ | ||
| (25 | R1 = [D-Glc-(1 → 4)- | [ | ||
| Arudoine | R1 = | [ | ||
| Robeneoside B | R1 = Solatriose; R2 = R4 = R5 = H; R3 = | [ | ||
| 27-Hydroxysolamargine | R1 = Chacotriose; R2 = R3 = R4 = H; R5 = OH | [ | ||
| 12-Hydroxysolamargine | R1 = Chacotriose; R2 = R4 = R5 = H; R3 = | [ | ||
| R1 = Chacotriose; R2 = R3 = R4 = R5 = H | [ | |||
| R1 = Solatriose; R2 = R3 = R4 = R5 = H | [ | |||
| (22 | R1 = | [ | ||
| R1 = 6-Ac- | L | [ | ||
| (22 | R1 = Chacotriose; R2 = R3 = R4 = R5 = H; C16 = | [ | ||
| R1 = | [ | |||
| R1 = | [ | |||
| Solanigroside P | R1 = | [ | ||
| Khasianine | R1 = | [ | ||
| R1 = | [ | |||
| 7 | R1 = | [ | ||
| 7 | R1 = Chacotriose; R2 = | [ | ||
| 7 | R1 = Solatriose; R2 = | [ | ||
| Solasodine | R1 = R2 = R3 = R4 = R5 = H | [ | ||
| R1 = | [ | |||
| (25 | R1 = Chacotriose; R2 = O; R3 = R4 = R5 = H | [ | ||
| Solasodiene | [ | |||
| (22 | [ | |||
| (22 | [ | |||
| (22 | R = | [ | ||
| Soladunalinidine | R = | [ | ||
| 3- | R = | [ | ||
| Caavuranamide | R = | [ | ||
| 5-Tomatidan-3-one | R = O | [ | ||
| 5 | [ | |||
| 4-Tomatiden-3-one | [ | |||
| (25 | R = Chacotriose | [ |
Fig. 11Structures of solanidine type steroidal alkaloids 527–555
Structures and sources of solanidine type steroidal alkaloids 527–555
| No | Compounds | Substitution groups and others | Sources | References |
|---|---|---|---|---|
| R1 = Chacotriose; R2 = R3 = R5 = H; R4 = R6 = CH3 | [ | |||
| R1 = Solatriose; R2 = R3 = R5 = H; R4 = R6 = CH3 | [ | |||
| Leptine I | R1 = Chacotriose; R2 = R3 = H; R4 = R6 = CH3; R5 = OAc | [ | ||
| Leptinine I | R1 = Chacotriose; R2 = R3 = H; R4 = R6 = CH3; R5 = OH | [ | ||
| Leptine II | R1 = Solatriose; R2 = R3 = H; R4 = R6 = CH3; R5 = OAc | [ | ||
| Leptinine II | R1 = Solatriose; R2 = R3 = H; R4 = R6 = CH3; R5 = OH | [ | ||
| Dehydrodemissine | R1 = Lycotetraose; R2 = R3 = R5 = H; R4 = R6 = CH3 | [ | ||
| Dehydrocommersonine | R1 = Commertetraose; R2 = R3 = R5 = H; R4 = R6 = CH3 | [ | ||
| Solanidine | R1 = R2 = R3 = R5 = H; R4 = R6 = CH3 | [ | ||
| Epirubijervin | R1 = R2 = R5 = H; R3 = | [ | ||
| Camtschatcanidine | R1 = R2 = R3 = R5 = H; R4 = CH3; R6 = CH2OH | [ | ||
| Oligoglycoside | R1 = [ | [ | ||
| (22 | R1 = R2 = R3 = R5 = H; R4 = R6 = CH3 | [ | ||
| (3 | R1 = 6-deoxy- | [ | ||
| (3 | R1 = 6-deoxy- | [ | ||
| (3 | R1 = 6-deoxy- | [ | ||
| Isorubijervine | R1 = R2 = R3 = R5 = H; R4 = CH2OH; R6 = CH3 | [ | ||
| Rubijervine | R1 = R2 = R5 = H; R3 = | [ | ||
| Demissine | R1 = Lycotetraose; R2 = H | [ | ||
| Commersonine | R1 = Commertetraose; R2 = H | [ | ||
| Demissidine | R1 = R2 = H | [ | ||
| Dihydro- | R1 = | [ | ||
| Dihydrosolanine | R1 = Solatriose; R2 = H | [ | ||
| (22 | R = H | [ | ||
| (3 | R = 6-deoxy- | [ | ||
| 15,16-Seco-22 | R = | [ | ||
| (22 | [ | |||
| (3 | R = 4- | [ | ||
| ( | [ |
Fig. 12Structures of verazine type steroidal alkaloids 556–601
Structures and sources of verazine type steroidal alkaloids 556–601
| No | Compounds | Substitution groups and others | Sources | References |
|---|---|---|---|---|
| Hapepunine | R1 = R4 = R5 = R7 = H; R2 = R6 = CH3; R3 = | [ | ||
| Anrakorinine | R1 = R4 = R5 = R7 = H; R2 = CH2OH; R3 = | [ | ||
| Hapepunine 3- | R1 = | [ | ||
| Pingbeidinoside | R1 = H; R2 = R5 = R7 = CH3; R3 = | [ | ||
| Pingbeinine | R1 = R4 = H; R2 = R5 = CH3; R3 = | [ | ||
| Pingbeininoside | R1 = | [ | ||
| Hapepunine 3- | R1 = | [ | ||
| Muldamine | R1 = R2 = R4 = H; R3 = | [ | ||
| Stenophylline B | R1 = R2 = R3 = H; R4 = OH; R5 = R6 = | [ | ||
| Vertaline B | R1 = R2 = H; R3 = | [ | ||
| Veramiline-3- | R1 = | [ | ||
| Stenophylline- | R1 = | [ | ||
| Veramivirine | R1 = R3 = R4 = H; R2 = | [ | ||
| Oblonginine | R1 = R2 = R4 = H; R3 = | [ | ||
| Verazinine | R1 = | [ | ||
| Veranigrine | R1 = R3 = R4 = R5 = H; R2 = | [ | ||
| Veramitaline | R1 = R2 = R4 = R5 = H; R3 = | [ | ||
| (20 | R1 = R2 = R5 = H; R3 = | [ | ||
| (20 | R1 = | [ | ||
| (20 | R1 = | [ | ||
| Rhamnoveracintine | R = | [ | ||
| Puqietinone | R1 = H; R2 = | [ | ||
| Yibeinoside C | R1 = | [ | ||
| R1 = R3 = H; R2 = | [ | |||
| Puqietinonoside | R1 = | [ | ||
| (25 | R = | [ | ||
| (25 | R1 = H; R2 = | [ | ||
| (25 | R1 = | [ | ||
| (20 | R1 = H; R2 = | [ | ||
| (20 | R1 = | [ | ||
| Ebeietinone | [ | |||
| Verdinine | R1 = | [ | ||
| Fetisinine | R1 = | [ | ||
| Diacetylveralkamine | R1 = Ac; R2 = | [ | ||
| veralinine 3- | R1 = | [ | ||
| Tetrahydroveralkamine | [ | |||
| Deacetoxysolaphyllidine 3- | [ | |||
| 4-Keto-5,6-dihydro-(20 | [ | |||
| Allumine A | R = H | [ | ||
| Allumine B | R = | [ | ||
| Allumine C | R = | [ | ||
| Isoecliptalbine | [ | |||
| Spiraloside A | R = | [ | ||
| Spiraloside B | R = | [ | ||
| Spiraloside C | R = | [ | ||
| Tomatillidine 3- | R = X | [ |
Fig. 13Structures of others cholestane steroidal alkaloids 602–603
Structures and sources of samandarines 604–614
| No | Compounds | Substitution groups and others | Sources | References |
|---|---|---|---|---|
| Samandarine | R = | [ | ||
| Samandarone | R = O | [ | ||
| R = | [ | |||
| R = | [ | |||
| Samandaridine | [ | |||
| Cycloneosamandione | [ | |||
| Cycloneosamandaridin | [ | |||
| Samandenone | [ | |||
| Samandinine | [ | |||
| Samanine | R = | [ | ||
| Samanone | R = O | [ |
Fig. 14Structures of samandarines 604–614
Structures and sources of batrachotoxins 615–621
| No | Compounds | Substitution groups and others | Sources | References |
|---|---|---|---|---|
| Batrachotoxinin A | R = H | [ | ||
| Pseudobatrachotoxin | R = X1 | [ | ||
| Batrachotoxin | R = X2 | [ | ||
| Homobatrachotoxin | R = X3 | [ | ||
| Batrachotoxinin A-20 | R = COCHCHCH3 | [ | ||
| Batrachotoxinin A-20 | R = COCH2CH(OH)CH2CH3 | [ | ||
| Batrachotoxinin A-20 | R = Ac | [ |
Fig. 15Structures of batrachotoxins 615–621
Structures and sources of plakinamines 622–640
| No | Compounds | Substitution groups and others | Sources | References |
|---|---|---|---|---|
| Plakinamine A | R1 = R2 = R3 = H | [ | ||
| Plakinamine F | R1 = R2 = CH3; R3 = O | [ | ||
| Plakinamine B | R1 = | [ | ||
| Plakinamine H | R1 = | [ | ||
| 4 | R1 = | [ | ||
| Plakinamines C | [ | |||
| Plakinamines D | [ | |||
| Plakinamine E | [ | |||
| Plakinamine G | [ | |||
| Tetrahydroplakinamine A | R1 = | [ | ||
| Dihydroplakinamine K | R1 = | [ | ||
| Plakinamine I | [ | |||
| Plakinamine J | [ | |||
| Plakinamine K | R1 = CH3; R2 = | [ | ||
| Plakinamine N | R1 = R2 = H | [ | ||
| Plakinamine O | R1 = H; R2 = | [ | ||
| Plakinamine L | R = H | [ | ||
| Plakinamine M | R = | [ | ||
| Plakinamine P | [ |
Fig. 16Structures of plakinamines 622–640
Fig. 17Structures of cortistatins 641–651
Structures and sources of cortistatins 641–651
| No | Compounds | Substitution groups and others | Sources | References |
|---|---|---|---|---|
| Cortistatin A | R1 = H; R2 = H; H | [ | ||
| Cortistatin B | R1 = H; R2 = | [ | ||
| Cortistatin C | R1 = H; R2 = O | [ | ||
| Cortistatin D | R1 = OH; R2 = O | [ | ||
| Cortistatin E | R1 = H; R2 = X1 | [ | ||
| Cortistatin G | R1 = H; R2 = X2 | [ | ||
| Cortistatin H | R1 = H; R2 = X3 | [ | ||
| Cortistatin K | R1 = H; R2 = X4 | [ | ||
| Cortistatin L | R1 = | [ | ||
| Cortistatin F | R = X1 | [ | ||
| Cortistatin J | R = X4 | [ |
Structures and sources of cephalostatins 652–671
| No | Compounds | Substitution groups and others | Sources | References |
|---|---|---|---|---|
| Cephalostatin 1 | R1 = R2 = R3 = R4 = H | [ | ||
| Cephalostatin 2 | R1 = R2 = R3 = H; R4 = OH | [ | ||
| Cephalostatin 3 | R1 = CH3; R2 = R3 = H; R4 = OH | [ | ||
| Cephalostatin 10 | R1 = R2 = H; R3 = OCH3; R4 = OH | [ | ||
| Cephalostatin 11 | R1 = R3 = H; R2 = OCH3; R4 = OH | [ | ||
| Cephalostatin 18 | R1 = R2 = R4 = H; R3 = OCH3 | [ | ||
| Cephalostatin 19 | R1 = R3 = R4 = H; R2 = OCH3 | [ | ||
| Cephalostatin 4 | [ | |||
| Cephalostatin 5 | R = CH3 | [ | ||
| Cephalostatin 6 | R = H | [ | ||
| Cephalostatin 7 | [ | |||
| Cephalostatin 8 | [ | |||
| Cephalostatin 9 | R = H | [ | ||
| Cephalostatin 20 | R = OH | [ | ||
| Cephalostatin 12 | R = H | [ | ||
| Cephalostatin 13 | R = OH | [ | ||
| Cephalostatin 14 | R = H | [ | ||
| Cephalostatin 15 | R = CH3 | [ | ||
| Cephalostatin 16 | [ | |||
| Cephalostatin 17 | [ |
Fig. 18Structures of cephalostatins 652–671
Structures and sources of ritterazines 672–697
| No | Compounds | Substitution groups and others | Sources | References |
|---|---|---|---|---|
| Ritterazine A | R1 = R2 = OH | [ | ||
| Ritterazine T | R1 = R2 = H | [ | ||
| Ritterazine B | [ | |||
| Ritterazine C | [ | |||
| Ritterazine D | R = H | [ | ||
| Ritterazine E | R = CH3 | [ | ||
| Ritterazine F | R = | [ | ||
| Ritterazine H | R = O | [ | ||
| Ritterazine G | R1 = R2 = | [ | ||
| Ritterazine I | R1 = | [ | ||
| Ritterazine Y | R1 = R3 = H; R2 = | [ | ||
| Ritterazine J | R1 = R3 = OH; R2 = | [ | ||
| Ritterazine K | R1 = H; R2 = | [ | ||
| Ritterazine L | R1 = R3 = H; R2 = | [ | ||
| Ritterazine M | R1 = R3 = H; R2 = | [ | ||
| Ritterazine N | [ | |||
| Ritterazine O | [ | |||
| Ritterazine P | [ | |||
| Ritterazine Q | [ | |||
| Ritterazine R | [ | |||
| Ritterazine S | [ | |||
| Ritterazine U | [ | |||
| Ritterazine V | [ | |||
| Ritterazine W | [ | |||
| Ritterazine X | [ | |||
| Ritterazine Z | [ |
Fig. 19Structures of ritterazines 672–697
Fig. 20Structural abbreviations used in this review
Cytotoxic activity of steroidal alkaloids against tumor cell lines
| Compounds | Cells | Activity | References |
|---|---|---|---|
| Mokluangin A ( | Small cell lung cancer (NCI-H187) | IC50 = 30.6 μM | [ |
| Irehline ( | NCI-H187 | IC50 = 27.7 μM | [ |
| 3- | Oral epidermoid carcinoma (KB) | IC50 = 21.2 μM | [ |
| Paravallarine ( | KB | IC50 = 12.8 μM | [ |
| Pachysamine E ( | Mouse lymphoid neoplasm (P388) | IC50 = 0.46 μg/mL | [ |
| Parental and the Adriamycin (doxorubicin)-resistant subline of mouse leukemia (P388/ADM) | IC50 = 0.45 μg/mL | [ | |
| Hookerianine A ( | Colon cancer (SW480) | IC50 = 10.97 ± 1.36 μM | [ |
| Human prostate cancer (PC3) | IC50 = 32.97 ± 3.78 μM | [ | |
| Breast adenocarcinoma (MCF-7) | IC50 = 37.70 ± 0.99 μM | [ | |
| Human myelogenous leukemia (K562) | IC50 = 11.86 ± 0.82 μM | [ | |
| Vaganine A ( | Breast cancer (MB-MDA-231) | IC50 = 0.18 μM | [ |
| Epipachysamine D ( | Human myeloid leukemia (HL-60) | IC50 = 2.96 μM; IC50 = 2.87 μM | [ |
| Breast adenocarcinoma (MCF-7) | IC50 = 28.92 ± 1.22 μM | [ | |
| Epipachysamine E ( | Human melanoma (B16) | IC50 = 2.5 μg/mL | [ |
| Shionogi carcinoma (SC115) | IC50 = 3.4 μg/mL | [ | |
| Mouse lymphoid neoplasm (P388) | IC50 = 0.56 μg/mL | [ | |
| Parental and the adriamycin (doxorubicin)-resistant subline of mouse leukemia (P388/ADM) | IC50 = 0.66 μg/mL | [ | |
| Sarcovagine D ( | Hepatocellular carcinoma (SMMC-7721) | IC50 = 16.69 μM | [ |
| Lung cancer (A-549) | IC50 = 11.17 μM | [ | |
| Breast cancer (SK-BR-3) | IC50 = 4.17 μM; IC50 = 2.25 μM | [ | |
| Pancreatic cancer (PANC-1) | IC50 = 10.76 μM; IC50 = 2.70 μM | [ | |
| Human myeloid leukemia (K562) | IC50 = 3.53 μM | [ | |
| Gastric carcinoma (SGC7901) | IC50 = 4.87 μM | [ | |
| Sarsaligenine A ( | Human myeloid leukemia (HL-60) | IC50 = 2.87 μM | [ |
| Human myeloid leukemia (K562) | IC50 = 8.48 μM | [ | |
| Gastric carcinoma (SGC7901) | IC50 = 29.94 μM | [ | |
| Breast cancer (SK-BR-3) | IC50 = 10.14 μM | [ | |
| Pancreatic cancer (PANC-1) | IC50 = 12.34 μM | [ | |
| Sarsaligenine B ( | Human myeloid leukemia (HL-60) | IC50 = 3.61 μM | [ |
| Human myeloid leukemia (K562) | IC50 = 17.10 μM | [ | |
| Gastric carcinoma (SGC7901) | IC50 = 21.53 μM | [ | |
| Breast cancer (SK-BR-3) | IC50 = 17.89 μM | [ | |
| Pancreatic cancer (PANC-1) | IC50 = 32.84 μM | [ | |
| Holamine ( | Human myeloid leukemia (HL-60) | IC50 = 24.22 μM | [ |
| Human colon adenocarcinoma (HT-29) | IC50 = 31.06 μM | [ | |
| Human cervical cancer (HeLa) | IC50 = 51.42 μM | [ | |
| Human breast adenocarcinoma (MCF-7) | IC50 = 42.82 μM | [ | |
| Non-cancerous human fibroblast (KMST-6) | IC50 = 102.95 μM | [ | |
| Pachysanonin ( | Lewis lung carcinoma (LLC) | IC50 = 2.0 ± 0.3 μg/mL | [ |
| Funtumine ( | Human colon adenocarcinoma (HT-29) | IC50 = 22.36 μM | [ |
| Human cervical cancer (HeLa) | IC50 = 46.17 μM | [ | |
| Human breast adenocarcinoma (MCF-7) | IC50 = 52.69 μM | [ | |
| Non-cancerous human fibroblast (KMST-6) | IC50 = 85.45 μM | [ | |
| Pachystermine A ( | Human melanoma (B16) | IC50 = 6.3 μg/mL | [ |
| Breast cancer (MB-MDA-231) | IC50 = 0.32 μM | [ | |
| Terminamine A ( | MB-MDA-231 | IC50 = 0.18 μM | [ |
| Terminamine B ( | MB-MDA-231 | IC50 = 0.20 μM | [ |
| Terminamine C ( | MB-MDA-231 | IC50 = 0.08 μM | [ |
| Terminamine D ( | MB-MDA-231 | IC50 = 0.20 μM | [ |
| Terminamine E ( | MB-MDA-231 | IC50 = 0.07 μM | [ |
| Hookerianine B ( | Colon cancer (SW480) | IC50 = 5.97 ± 0.13 μM | [ |
| Human hepatocarcinoma (SMMC-7721) | IC50 = 16.19 ± 0.56 μM | [ | |
| Human prostate cancer (PC3) | IC50 = 11.57 ± 0.86 μM | [ | |
| Breast adenocarcinoma (MCF-7) | IC50 = 19.44 ± 1.70 μM | [ | |
| Human myelogenous leukemia (K562) | IC50 = 7.95 ± 0.02 μM | [ | |
| Veratramine ( | Lung cancer (A549) | IC50 = 8.9 μmol/L | [ |
| Pancreatic cancer (PANC-1) | IC50 = 14.5 μmol/L | [ | |
| Hh-dependent (SW1990) | IC50 = 26.1 μmol/L | [ | |
| Hh-dependent (NCI-H249) | IC50 = 8.5 μmol/L | [ | |
| Human glioma (SF188) | IC50 = 97.8 μmol/L | [ | |
| Germine ( | Hh-dependent (SW1990) | IC50 = 47.2 μmol/L | [ |
| Hh-dependent (NCI-H249) | IC50 = 24.1 μmol/L | [ | |
| Cyclopamine ( | Lung cancer (A549) | IC50 = 14.4 μmol/L | [ |
| pancreatic cancer (PANC-1) | IC50 = 29.3 μmol/L | [ | |
| Hh-dependent (SW1990) | IC50 = 48.6 μmol/L | [ | |
| Hh-dependent (NCI-H249) | IC50 = 4.4 μmol/L | [ | |
| Human pancreatic adenocarcinoma (HPAF-2) | IC50 = 8.79 ± 0.94 μM | [ | |
| Human pancreatic adenocarcinoma cell line Panc 10.05 | IC50 = 11.33 ± 0.41 μM | [ | |
| Human pancreatic adenocarcinoma cell line Panc 8.13 | IC50 = 14.49 ± 0.85 μM | [ | |
| Human pancreatic adenocarcinoma cell line Panc 2.03 | IC50 = 16.57 ± 0.27 μM | [ | |
| Human pancreatic adenocarcinoma cell line AsPC-1 | IC50 = 16.74 ± 1.30 μM | [ | |
| Human pancreatic adenocarcinoma cell line CFPAC-1 | IC50 = 19.59 ± 0.32 μM | [ | |
| Human pancreatic adenocarcinoma cell line BxPC-3 | IC50 = 36.17 ± 0.31 μM | [ | |
| Human pancreatic adenocarcinoma cell line S2013 | IC50 = 45.09 ± 1.27 μM | [ | |
| Breast cancer (MDA-MB-231) | IC50 = 26.4 ± 3.6 μg/mL | [ | |
| Gastric adenocarcinoma (KATO-III) | IC50 = 16.4 ± 10.0 μg/mL | [ | |
| Prostate cancer (PC3) | IC50 = 3.0 ± 0.3 μg/mL | [ | |
| Human adenocarcinoma (H441) | IC50 = 3.0 μM | [ | |
| Squamous cell lung carcinoma (H520) | IC50 = 6.7 μM | [ | |
| Large cell lung cancer (H661) | IC50 = 7.2 μM | [ | |
| Small cell lung cancer (H69) | IC50 = 5.8 μM | [ | |
| Cervical carcinoma (HeLa) | IC50 = 6.0 μM | [ | |
| Lung cancer (A549) | IC50 = 8.0 μM | [ | |
| Breast adenocarcinoma (MCF-7) | IC50 = 2.1 μM | [ | |
| Human myelogenous leukemia (K562) | IC50 = 5.2 μM | [ | |
| Colon cancer cell line (HCT116) | IC50 = 3.8 μM | [ | |
| Human primary glioblastoma (U87) | IC50 = 3.2 μM | [ | |
| Liver cancer (HepG2) | IC50 = 2.5 μM | [ | |
| HepG2 | IC50 = 14.47 μg/mL | [ | |
| Plakinamine H ( | Rat glioma (C6) | IC50 = 9.0 μg/mL | [ |
| Plakinamine G ( | C6 | IC50 = 6.8 μg/Ml | [ |
| Tetrahydroplakinamine A ( | C6 | IC50 = 1.4 μg/mL | [ |
| Dihydroplakinamine K ( | Human colon tumor (HCT-116) | IC50 = 1.4 μM | [ |
| Plakinamine I ( | HCT-116 | IC50 = 5.2 μM | [ |
| Plakinamine J ( | HCT-116 | IC50 = 10.6 μM | [ |
| Plakinamine K ( | HCT-116 | IC50 = 6.1 μM | [ |
| Cephalostatin 1 ( | Pancreas adenocarcinoma (BXPC-3) | GI50 = 0.044 nM | [ |
| Breast adenocarcinoma (MCF-7) | GI50 = 0.099 nM | [ | |
| Glioblastoma (SF-268) | GI50 = 1.60 nM | [ | |
| Human lung large cell carcinoma (NCI-H460) | GI50 = 0.044 nM | [ | |
| Colon carcinoma (KM20L2) | GI50 = 0.066 nM | [ | |
| Human prostate adenocarcinoma (DU-145) | GI50 = 0.11 nM | [ | |
| Cephalostatin 2 ( | Pancreas adenocarcinoma (BXPC-3) | GI50 = 0.022 nM | [ |
| Breast adenocarcinoma (MCF-7) | GI50 = 0.022 nM | [ | |
| Glioblastoma cells (SF-268) | GI50 = 0.12 nM | [ | |
| Human lung large cell carcinoma (NCI-H460) | GI50 = 0.0056 nM | [ | |
| Colon carcinoma (KM20L2) | GI50 = 0.0060 nM | [ | |
| Human prostate adenocarcinoma (DU-145) | GI50 = 0.11 nM | [ | |
| Cephalostatin 9 ( | Pancreas adenocarcinoma (BXPC-3) | GI50 = 14 nM | [ |
| Breast adenocarcinoma (MCF-7) | GI50 = 110 nM | [ | |
| Glioblastoma (SF-268) | GI50 = 150 nM | [ | |
| Human lung large cell carcinoma (NCI-H460) | GI50 = 39 nM | [ | |
| Colon carcinoma (KM20L2) | GI50 = 58 nM | [ | |
| Cephalostatin 20 ( | Pancreas adenocarcinoma (BXPC-3) | GI50 = 16 nM | [ |
| Breast adenocarcinoma (MCF-7) | GI50 = 22 nM | [ | |
| Glioblastoma (SF-268) | GI50 = 36 nM | [ | |
| Human lung large cell carcinoma (NCI-H460) | GI50 = 6.00 nM | [ | |
| Colon carcinoma (KM20L2) | GI50 = 7.20 nM | [ | |
| Human prostate adenocarcinoma (DU-145) | GI50 = 210 nM | [ | |
| Ritterazine A ( | Murine leukemia (P388) | IC50 = 0.0035 μg/mL | [ |
| Ritterazine T ( | P388 | IC50 = 0.46 μg/mL | [ |
| Ritterazine B ( | P388 | IC50 = 0.00015 μg/mL | [ |
| Ritterazine C ( | P388 | IC50 = 0.092 μg/mL | [ |
| Ritterazine D ( | P388 | IC50 = 0.016 μg/mL | [ |
| Ritterazine E ( | P388 | IC50 = 0.0035 μg/mL | [ |
| Ritterazine F ( | P388 | IC50 = 0.00073 μg/mL | [ |
| Ritterazine H ( | P388 | IC50 = 0.016 μg/mL | [ |
| Ritterazine G ( | P388 | IC50 = 0.00073 μg/mL | [ |
| Ritterazine I ( | P388 | IC50 = 0.014 μg/mL | [ |
| Ritterazine Y ( | P388 | IC50 = 0.0035 μg/mL | [ |
| Ritterazine J ( | P388 | IC50 = 0.013 μg/mL | [ |
| Ritterazine K ( | P388 | IC50 = 0.0095 μg/mL | [ |
| Ritterazine L ( | P388 | IC50 = 0.010 μg/mL | [ |
| Ritterazine M ( | P388 | IC50 = 0.015 μg/mL | [ |
| Ritterazine N ( | P388 | IC50 = 0.46 μg/mL | [ |
| Ritterazine O ( | P388 | IC50 = 2.1 μg/mL | [ |
| Ritterazine P ( | P388 | IC50 = 0.71 μg/mL | [ |
| Ritterazine Q ( | P388 | IC50 = 0.57 μg/mL | [ |
| Ritterazine R ( | P388 | IC50 = 2.1 μg/mL | [ |
| Ritterazine S ( | P388 | IC50 = 0.46 μg/mL | [ |
| Ritterazine U ( | P388 | IC50 = 2.1 μg/mL | [ |
| Ritterazine V ( | P388 | IC50 = 2.1 μg/mL | [ |
| Ritterazine W ( | P388 | IC50 = 3.2 μg/mL | [ |
| Ritterazine X ( | P388 | IC50 = 3.0 μg/mL | [ |
| Ritterazine Z ( | P388 | IC50 = 2.0 μg/mL | [ |
Cholinesterase-inhibiting activities of steroidal alkaloids
| Compounds | IC50/μM | References | |
|---|---|---|---|
| AChE | BChE | ||
| Salonine B ( | n.a | 4.5 | [ |
| 2-Hydroxysalignamine ( | 82.5 | 20.9 | [ |
| 48.6 | 10.5 | [ | |
| Sarsalignone ( | 7 | 2.2 | [ |
| Sarsaligenone ( | 5.8 | 4.3 | [ |
| Alkaloid C ( | 48.6 | 10.5 | [ |
| Salignarine F ( | 30.2 | 1.9 | [ |
| Saracosine ( | 20 | 3.8 | [ |
| Sarcodinine ( | 40 | 12.5 | [ |
| Sarcovagine C ( | 8 | 0.3 | [ |
| Vaganine A ( | 8.6 | 2.3 | [ |
| Sarcorine ( | 70 | 10.3 | [ |
| Saligcinnamide ( | 20 | 4.8 | [ |
| 10.1 | 3.2 | [ | |
| Epipachysamine D ( | 28.9 | 2.8 | [ |
| Salignenamide A ( | 50.6 | 4.6 | [ |
| Iso- | 6.3 | 4.07 | [ |
| Saligenamide C ( | 61.3 | 38.3 | [ |
| Saligenamide F ( | 6.3 | 4.1 | [ |
| 2 | 78.2 | 28.9 | [ |
| Axillarine C ( | 227.9 | 18 | [ |
| Axillarine F ( | 182.4 | 18.2 | [ |
| Salonine A ( | 33.4 | 32.7 | [ |
| Dictyophlebine ( | 6.2 | 3.6 | [ |
| Hookerianamine A ( | 18.9 | 0.9 | [ |
| Isosarcodine ( | 10.3 | 1.9 | [ |
| Hookerianamide B ( | 26.4 | 0.7 | [ |
| Hookerianamide C ( | 23.2 | 0.6 | [ |
| Hookerianamide E ( | 15.9 | 6 | [ |
| Hookerianamide G ( | 11.4 | 1.5 | [ |
| Hookerianamide I ( | 34.1 | 0.3 | [ |
| Sarcovagine D ( | 2.2 | 2.3 | [ |
| Sarcovagenine C ( | 1.5 | 0.7 | [ |
| Axillaridine A ( | 5.21 | 2.5 | [ |
| 2,3-Dehydrosarsalignone ( | 7 | 32.3 | [ |
| Phulchowkiamide A ( | 0.5 | 0.4 | [ |
| Hookerianamide F ( | 1.6 | 7.2 | [ |
| Hookerianamide H ( | 2.9 | 1.9 | [ |
| (−)-Vaganine D ( | 46.9 | 10 | [ |
| 5,6-Dihydrosarconidine ( | 20.3 | 1.9 | [ |
| 16-Dehydrosarcorine ( | 12.5 | 3.9 | [ |
| Hookerianamide A ( | 82.7 | 200 | [ |
| Saligenamide D ( | 185.2 | 23.7 | [ |
| 2-Hydroxysalignarine E ( | 16 | 6.9 | [ |
| Salonine C ( | 7.8 | 32.3 | [ |
| Buxasamarine ( | 25.4 | 0.7 | [ |
| Cycloprotobuxine C ( | 38.8 | 2.7 | [ |
| Cyclovirobuxeine A ( | 105.7 | 2 | [ |
| (+)-Benzoylbuxidienine ( | 35 | No | [ |
| Hyrcatrienine ( | No | 1.7 | [ |
| Hyrcanone ( | 145 | 20 | [ |
| (+)- | 17 | No | [ |
| (+)-7-Deoxy- | 13 | No | [ |
| Impericine ( | 67.97 ± 2.46 | 1.607 | [ |
| Forticine ( | > 500 | 100.5 ± 0.445 | [ |
| Delavine ( | 105.5 ± 1.45 | 1.706 ± 0.11 | [ |
| Persicanidine A ( | 352.2 ± 4.03 | 4.245 ± 0.079 | [ |
n.t. not tested, n.a. not active